Adaptimmune Therapeutics PLC (ADAP)

0.6199 -0.03 (-5.26%) USD  |  NASDAQ  |  Jan 08, 15:11
More

Adaptimmune Therapeutics Cash and Short Term Investments (Quarterly): 186.09M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ADAP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals PLC 6.394M
TC BioPharm (Holdings) PLC 1.270M
Verona Pharma PLC 336.04M
Autolus Therapeutics PLC 657.07M
NuCana PLC 15.19M